In conclusion, our study demonstrated the pre-clinical development of a PSMA targeted minibody, IR800-IAB2M and its first-in-man utilisation for the intraoperative detection of prostate cancer tissue in lymph nodes and extra-prostatic tissues with favourable outcomes. This evidence concerns the gene FOLH1 and Familial prostate cancer.